Amicus Therapeutics, Inc.

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC FOLD

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

857,834

Value ($000)

12,216

Weight

0.0%

2013 Q4 - 2025 Q4 (27 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	12,216	0.0%	857,834	12/31/2025
2025 Q3	11/14/2025	6,485	0.0%	822,931	9/30/2025
2025 Q2	8/14/2025	7,196	0.0%	1,255,803	6/30/2025
2025 Q1	5/19/2025	8,751	0.0%	1,072,474	3/31/2025
2024 Q4	2/14/2025	9,031	0.0%	958,671	12/31/2024
2024 Q3	11/14/2024	5,199	0.0%	486,769	9/30/2024
2024 Q2	8/14/2024	5,298	0.0%	534,079	6/30/2024
2024 Q1	5/15/2024	2,960	0.0%	251,233	3/31/2024
2023 Q4	2/14/2024	3,658	0.0%	257,800	12/31/2023
2023 Q3	11/13/2023	2,992	0.0%	246,039	9/30/2023
2023 Q2	8/11/2023	3,010	0.0%	271,402	6/30/2023
2023 Q1	5/15/2023	3,010	0.0%	271,402	3/31/2023
2022 Q4	2/14/2023	3,048	0.0%	249,671	12/31/2022
2022 Q3	11/14/2022	2,306	0.0%	220,894	9/30/2022
2022 Q2	8/12/2022	2,916	0.0%	271,479	6/30/2022
2022 Q1	5/16/2022	2,548	0.0%	269,026	3/31/2022
2021 Q4	2/14/2022	3,228	0.0%	279,487	12/31/2021
2021 Q3	11/15/2021	2,728	0.0%	285,641	9/30/2021
2021 Q2	8/16/2021	3,131	0.0%	324,837	6/30/2021
2021 Q1	5/14/2021	3,108	0.0%	314,549	3/31/2021
2020 Q4	3/1/2021	6,652	0.0%	288,092	12/31/2020
2020 Q3	11/13/2020	21,259	0.0%	1,505,578	9/30/2020
2020 Q2	8/14/2020	4,381	0.0%	290,534	6/30/2020
2020 Q1	5/15/2020	2,722	0.0%	294,595	3/31/2020
2019 Q4	2/14/2020	2,691	0.0%	276,309	12/31/2019
2014 Q1	5/23/2014	5,083	0.0%	2,455,400	3/31/2014
2013 Q4	1/31/2014	5,770	0.0%	2,455,400	12/31/2013